065170 — BL PharmTech Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for BL PharmTech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-17,453	-16,587	-20,107	-13,649	142
Depreciation
Amortisation
Non-Cash Items	28,721	22,029	21,556	13,080	955
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-9,231	-2,171	-1,801	-14,052	6,047
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	3,625	5,804	3,097	-10,998	7,992
Capital Expenditures	-23,464	-17,626	-587	-1,708	-312
Purchase of Fixed Assets
Other Investing Cash Flow Items	1,192	-16,092	909	-1,665	15,606
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities	-22,272	-33,718	322	-3,374	15,294
Financing Cash Flow Items	5	—	—	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	9,629	17,630	5,840	-2,322	-17,702
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-9,024	-10,342	9,372	-16,728	5,584